Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in miceThomas E Sussan, Tirumalai Rangasamy, David J Blake, et al.
Environment International|April 14, 2019
Waterpipe tobacco smoke: Characterization of toxicants and exposure biomarkers in a cross-sectional study of waterpipe employeesBekir Kaplan, Thomas Sussan, Ana Rule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2020
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical OutcomesAnju Singh, Anneleen Daemen, Dorothee Nickles, et al.
Archiv Der Pharmazie|December 23, 2011
Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: structure-activity analysisSarvesh Kumar, Chandra Shekhar Reddy L, Yogesh Kumar, et al.
Communications Biology|October 30, 2022
Loss of E-cadherin is causal to pathologic changes in chronic lung diseaseBaishakhi Ghosh, Jeffrey Loube, Shreeti Thapa, et al.
Circulation|May 14, 2008
Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategyAn L Moens, Eiki Takimoto, Carlo G Tocchetti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancerAnju Singh, Christian Ruiz, Kavita Bhalla, et al.
Nature Medicine|May 18, 2010
Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysemaToshinori Yoshida, Igor Mett, Anil K Bhunia, et al.
American Journal of Respiratory Cell and Molecular Biology|November 17, 2023
Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary DiseaseBonnie H Yeung-Luk, Ara Wally, Carter Swaby, et al.
ACS Chemical Biology|August 24, 2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H Oh, et al.
Pageof 18